4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-018715
Director sold 6,698 shares at $6.11 ($40,925)
- Director acquired 6,820 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HEGGIE THERESA · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-12 | Grant or award : show line 1 in the form | +6,820 | 59,550 | D | ||
| 2024-06-14 | Sale : show line 2 in the form | −6,698 | $6.11 | $40,925 | 52,852 | D |
| Open-market sales · 6,698 sh · avg $6.11 · $40,925 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-12 | Grant or award : show line 3 in the form Automatic Stock Option Grant | +49,933 | 49,933 | D |
Loading xslF345X05/form4.xml…